Amino Thrust Pina Colada
En vente sur le marché américain (selon le DSLD)
Labrada, food supplement from the US market
Amino Thrust Pina Colada (Labrada), a food supplement au code-barres 710779335264, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/2340).
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Labrada
- Barcode
- 710779335264
- Form
- Powder
- One serving
- 16 g
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Coconut Water concentrate, Malic Acid, Coconut Oil Creamer, Natural & Artificial flavors, Sucralose, Silicon Dioxide, Acesulfame Potassium
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 10 Calorie(s) |
| Total Fat | Fat | 0 Gram(s) |
| Total Carbohydrates | Carbohydrate | 2 Gram(s) |
| Sugar | Carbohydrate | 1 Gram(s) |
| Vitamin C | Vitamin | 100 mg |
| Calcium | Mineral | 18 mg |
| Sodium | Mineral | 15 mg |
| Potassium | Mineral | 35 mg |
| Amino Thrust Amino Matrix | Blend | not stated |
| L-Leucine, Micronized | Amino acid | 500 mg |
| L-Isoleucine, Micronized | Amino acid | 250 mg |
| L-Valine, Micronized | Amino acid | 250 mg |
| micronized Taurine | Other substance | 500 mg |
| L-Glutamine, Micronized | Amino acid | 500 mg |
| L-Arginine Hydrochloride, Micronized | Amino acid | 500 mg |
| CarnoSyn | Amino acid | 500 mg |
| L-Tyrosine, Micronized | Amino acid | 250 mg |
| L-Histidine, Micronized | Amino acid | 250 mg |
| L-Lysine, Micronized | Amino acid | 250 mg |
| L-Phenylalanine, Micronized | Amino acid | 250 mg |
| L-Threonine, Micronized | Amino acid | 250 mg |
| L-Methionine, Micronized | Amino acid | 250 mg |
| Amino Thrust Energy Matrix | Blend | not stated |
| Caffeine | Other substance | 100 mg |
| Green Tea extract (Camellia sinensis) | Plant | 20 mg |
| Green Coffee extract | Plant | 20 mg |
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Caffeine
Read the warning, when it applies and the studies cited
CAFFEINE
Route of administration: Oral (Higdon and Frei 2006)
Cautions and warnings
Applies to products providing 100 mg to 400 mg caffeine, per day1.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).
7 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
1Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.
Applies to products providing more than 300 mg caffeine, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant, breastfeeding, or attempting to conceive (Nawrot et al. 2003).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 400 mg or more caffeine, per day.
When using this product avoid taking other health products, foods or beverages that contain caffeine and/or increase blood pressure (FDA 2023; Bui et al. 2006; Bouchard et al. 2005; Haller et al. 2005; NIH 2004; Berardi et al. 2002; Vahedi et al. 2000; Zimmerman 1992).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing more than 400 mg caffeine per day.
Do not use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).
7 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if hypersensitivity/allergy occurs (Infante et al. 2003; Hinrichs et al. 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 200 mg or more caffeine, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms such as chest pain and irregular heartbeat occur (Higgins and Babu 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 400 mg caffeine, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if nervousness, anxiety, insomnia, tremor and/or headache occur (IOM 2001, Zhang 2001, Sawynok 1995).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except those making a diuretic claim1.
When using this product diuretic effect may occur.
1Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Labrada
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.